Literature DB >> 1933349

Excitatory effects of cholecystokinin octapeptide on rat nodose ganglion cells in vitro.

N J Dun1, S Y Wu, C W Lin.   

Abstract

Cholecystokinin octapeptide (CCK-8) applied by pressure evoked in the majority of rat nodose ganglion cells a rapid depolarization associated with a fall of membrane resistance and in a few cells a slow depolarization accompanied by an increase of membrane resistance. The fast depolarizations were increased and decreased by membrane hyperpolarization and depolarization; the extrapolated reversal potential was about -10 mV. The response was depressed in a Na-free solution and by d-tubocurarine (10-100 microM) but not in a Cl-deficient solution. It is concluded that CCK-8 depolarized the nodose ganglion cells by increasing cation conductances and in a few cells it also produced a slow excitation, the mechanism of which remains to be established.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1933349     DOI: 10.1016/0006-8993(91)90562-a

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  In vitro analysis of the effects of cholecystokinin on rat brain stem motoneurons.

Authors:  Zhongling Zheng; Mark W Lewis; R Alberto Travagli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-12-09       Impact factor: 4.052

2.  Effects of leptin on cat intestinal vagal mechanoreceptors.

Authors:  Stéphanie Gaigé; Anne Abysique; Michel Bouvier
Journal:  J Physiol       Date:  2002-09-01       Impact factor: 5.182

Review 3.  Pharmacology of vagal afferent influences on disordered breathing during sleep.

Authors:  David W Carley; Miodrag Radulovacki
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

4.  Comparative pharmacology of cholecystokinin induced activation of cultured vagal afferent neurons from rats and mice.

Authors:  Dallas C Kinch; James H Peters; Steven M Simasko
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.